Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19 Ng, Kenneth K | The University of Calgary | Operating Grant | $416,000 CIHR Alberta 2020 Read More